Active Tolerance Induction and Prevention of Autoimmune Diabetes by Immunogene Therapy Using Recombinant Adenoassociated Virus Expressing Glutamic Acid Decarboxylase 65 Peptide GAD500

Active Tolerance Induction and Prevention of Autoimmune Diabetes by Immunogene Therapy Using Recombinant Adenoassociated Virus Expressing Glutamic Acid Decarboxylase 65 Peptide GAD500–585

Published:2005-04-06 Issue:8 Volume:174 Page:4516-4524
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J Immunol

Author:

Han Gencheng,Li Yan,Wang Jianan,Wang Renxi,Chen Guojiang,Song Lun,Xu Ruonan,Yu Ming,Wu Xiaobing,Qian Jiahua,Shen Beifen

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference51 articles.

1. Insulin-Dependent Diabetes Mellitus as an Autoimmune Disease

2. The NOD mouse model of type 1 diabetes: As good as it gets?

3. Autoimmune diabetes results from genetic defects manifest by antigen presenting cells

4. The Role of CD4 vs. CD8 T Cells in IDDM

5. Islet cell autoantigens in insulin-dependent diabetes.

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathophysiological Effects of Autoantibodies in Autoimmune Encephalitides;Cells;2023-12-20

2. An update on malignant tumor-related stiff person syndrome spectrum disorders: clinical mechanism, treatment, and outcomes;Frontiers in Neurology;2023-10-04

3. Noncontiguous T cell epitopes in autoimmune diabetes: From mice to men and back again;Journal of Biological Chemistry;2021-07

4. GAD antibodies in neurological disorders — insights and challenges;Nature Reviews Neurology;2020-05-26

5. Engineering cell-based therapies to interface robustly with host physiology;Advanced Drug Delivery Reviews;2016-10